---
title: "Health Canada licenses Symplicity Spyral radiofrequency renal denervation system to treat hypertension"
date: "2024-03-19T14:16:52.000Z"
publishedDate: "19 mars 2024"
summary: "Medtronic has received a license from Health Canada for its Symplicity Spyral multi-electrode renal denervation (RDN) system. This is indicated for the management of essential hypertension in patients for whom blood pressure remains uncontrolled despite lifestyle modifications and guideline-driven medical therapy with antihypertensive medications, or when guideline-driven therapy is poorly tolerated."
importance: ""
sourceUrl: "https://vascularnews.com/health-canada-symplicity-renal-denervation-system/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-03-19-health-canada-licenses-symplicity-spyral-radiofrequency-renal-denervation-system-to-treat-hypertension"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2024/03/RDN-spyral-pic-crop.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/health-canada-symplicity-renal-denervation-system/"
---

![Health Canada licenses Symplicity Spyral radiofrequency renal denervation system to treat hypertension](https://vascularnews.com/wp-content/uploads/sites/7/2024/03/RDN-spyral-pic-crop.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/health-canada-symplicity-renal-denervation-system/*

## L’essentiel

Medtronic has received a license from Health Canada for its Symplicity Spyral multi-electrode renal denervation (RDN) system. This is indicated for the management of essential hypertension in patients for whom blood pressure remains uncontrolled despite lifestyle modifications and guideline-driven medical therapy with antihypertensive medications, or when guideline-driven therapy is poorly tolerated.

## Lien source

https://vascularnews.com/health-canada-symplicity-renal-denervation-system/
